
|Podcasts|December 1, 2021
Navigating New State Drug Price Transparency Laws
Author(s)Model N
As the State Drug Pricing Transparency Program expands, what does that mean for manufacturers? Jesse Mendelsohn, Vice President, Centers of Excellence for Model N, the leader in cloud revenue management solutions for life science companies, discusses challenges for manufacturers as the State Price Transparency Program expands how they should plan for this change and the solutions they will need.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Some Employers Are Scaling Back GLP-1 Coverage in 2027
2
Simplifying and Improving Global Pharma Operations
3
How Automation and AI Transform Pharmacovigilance
4
Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions
5




